作者:Daniel Flesch、Sun-Yee Cheung、Jurema Schmidt、Matthias Gabler、Pascal Heitel、Jan Kramer、Astrid Kaiser、Markus Hartmann、Mara Lindner、Kerstin Lüddens-Dämgen、Jan Heering、Christina Lamers、Hartmut Lüddens、Mario Wurglics、Ewgenij Proschak、Manfred Schubert-Zsilavecz、Daniel Merk
DOI:10.1021/acs.jmedchem.7b00903
日期:2017.8.24
As a cellular bile acid sensor, farnesoid X receptor (FXR) participates in regulation of bile acid, lipid and glucose homeostasis, and liver protection. Clinical results have validated FXR as therapeutic target in hepatic and metabolic diseases. To date, potent FXR agonists share a negatively ionizable function that might compromise their pharmacokinetic distribution and behavior. Here we report the development and characterization of a high-affinity FXR modulator not comprising an acidic residue.